Prediction: Intel Stock's Best Days Are Behind It -- and Here's the Chip Stock to Buy Instead

Intel’s first-quarter 2026 revenue rose 7% year over year and adjusted EPS more than doubled to $0.29, with the data center/AI segment up 22% to $5.1 billion. Despite the turnaround, the article argues Intel’s $427 billion market cap and roughly 73x annualized adjusted EPS leave the stock overvalued and vulnerable to muted returns. Broadcom is presented as the preferred chip name, with Q1 fiscal 2026 revenue up 29% to $19.3 billion and AI semiconductor revenue surging 106% to $8.4 billion.

Analysis

The market is rewarding Intel for a genuine operational inflection, but the setup has shifted from turnaround optionality to execution perfection. At this valuation, the stock is no longer trading on “can they fix it?” but on “can they keep compounding while supply stays tight and margins expand without a hiccup?” That creates asymmetric downside if growth normalizes, because the multiple has already capitalized several years of improvement.

The more interesting second-order effect is competitive pressure inside the AI semiconductor stack. If Intel keeps improving server CPU output and captures more AI-adjacent spend, it can squeeze lower-tier silicon vendors and niche CPU suppliers before it meaningfully threatens the high-end accelerator leaders. But the bigger beneficiary of the current capital spend cycle remains the company with sticky, co-designed custom silicon relationships and far more visible demand; that visibility deserves a premium, while Intel still looks like it is being repriced as if its rebound is already de-risked.

The contrarian miss in the market is not that Intel can’t continue improving—it likely can—but that improvement alone may not be enough to sustain further re-rating. In the next 3-12 months, the catalyst to fade is any sign of order normalization, mix deterioration, or capex intensity rising faster than gross margin leverage. Over a 1-3 year horizon, the key risk is that AI infrastructure spending consolidates into a smaller number of winners, leaving Intel with decent growth but not enough scarcity value to justify a premium multiple.

Broadcom looks better positioned as a relative long because its growth is not merely cyclical rebound, it is embedded in customer-specific roadmaps that are harder to displace. The stock is not cheap, but the gap between valuation and visibility is narrower than Intel’s. For portfolio construction, this argues more for a relative-value expression than a directional semiconductor beta bet.

Key Decisions for Investors

• Short INTC vs long AVGO as a 3-6 month pair trade: Intel is priced for flawless execution while Broadcom has more visible multi-year demand; target 15-20% relative underperformance in INTC if AI spending broadens less than expected.
• Avoid initiating fresh long INTC after the breakout; if already long, trim into strength and use a 10-15% trailing stop over the next 4-8 weeks to protect against multiple compression.
• Add AVGO on pullbacks over the next 1-2 months; preferred as the higher-conviction AI semiconductor exposure with better earnings visibility and less dependence on a single turnaround narrative.
• For event risk, buy downside protection on INTC 3-6 month puts if implied vol remains below realized vol; the stock is vulnerable to any guidance miss because the market is discounting several years of near-perfect execution.
• If looking for broader AI exposure, prefer AVGO over INTC on a 6-12 month horizon; risk/reward is better because upside comes from compounding demand, while downside is cushioned by sticky customer relationships.